Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
Health
Julia Musto

New blood test to detect colon cancer clears FDA approval

A new blood test aimed at helping doctors diagnose colorectal cancer - the second-leading cause of U.S. cancer deaths - was recently approved by the Food and Drug Administration.

SimpleScreen, made by the California biotech company Freenome, is designed for adults aged 45 and older who are at average risk for the life-threatening disease. It’s designed to detect DNA signals that are linked to colorectal cancer in this age group.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.